Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rangering i aksjer #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aksjekurs
$64.97
Sist synkronisert: 2024-05-20
Markedsverdi
$1.97B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Kategori

EPS for Alpine Immune Sciences, Inc. (ALPN)
EPS per March 2024 TTM: $-0.69
Ifølge de siste økonomiske rapportene og aksjekursen til Alpine Immune Sciences, Inc. er selskapets nåværende EPS (TTM) $-0.69. Ved slutten av 2022 hadde selskapet en EPS på $-1.73, en nedgang sammenlignet med EPS-en i 2021 som var $-1.98.
EPS-historikk for Alpine Immune Sciences, Inc. fra 2012 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.69 7.81%
2023 $-0.64 -63.01%
2022 $-1.73 -12.63%
2021 $-1.98 47.76%
2020 $-1.34 -42.24%
2019 $-2.32 -11.79%
2018 $-2.63 119.17%
2017 $-1.20 -85.22%
2016 $-8.12 -16.63%
2015 $-9.74 47.80%
2014 $-6.59 -7.18%
2013 $-7.10 69.05%
2012 $-4.20 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -2,610.14%
US
$27.74 -4,120.29%
NL
$-5.29 666.67%
AU
$-7.98 1,056.52%
US
- -
CH